Trial Profile
Effect of rivaroxaban and dabigatran versus vitamin K antagonists in patients with atrial fibrillation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 May 2015
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary) ; Rivaroxaban (Primary) ; Vitamin K antagonists
- Indications Thrombosis
- Focus Therapeutic Use
- 26 May 2015 New trial record